Genomenon

Genomic Evidence at the Gene and Variant Level

Ann Arbor, United States · Founded 2014 · $44.1M raised

Employees
51–200
Founded
2014
Business Model
B2B
Total Funding
$44.1M
Last Round
$5.5M Series BMay 2024
Rounds
9

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Genomenon is an AI-powered genomic intelligence company that transforms biomedical literature into actionable variant insights for clinical diagnostics and precision medicine. Its Mastermind platform organizes evidence across 27 million genomic variants, helping over 250 clinical labs and 75 pharma programs accelerate rare disease diagnosis and drug development.

Summary

Genomenon is a Biotech company based in Ann Arbor, United States, founded in 2014. It has raised $44.1M in total across 9 rounds, most recently a $5.5M Series B round in May 2024. Investors include Beringea, Spring Mountain Capital and Michigan Angel Fund.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BMay 2024
$5.5M

Sign up to see all 9 events

Funding: Seed through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Ultima Genomics

Ultima Genomics develops high-throughput DNA sequencing platforms that use open-wafer technology ...

Fremont, United States201–500Artificial Intelligence, Healthcare
Series ETotal funding$1.1BJun 2022
GRAILIPO

Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...

Menlo Park, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$2.1BJun 2026
Neuralink

Neuralink develops investigational implantable brain-computer interfaces that help people with pa...

Fremont, United States201–500Biotech, Healthcare
Series ETotal funding$1.2BJun 2025
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
Xaira Therapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...

South San Francisco, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.0BApr 2024

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Genomenon on Indexed.vc
<a href="https://indexed.vc/companies/genomenon"><img src="https://indexed.vc/api/badge/company/genomenon" alt="Genomenon on Indexed.vc" width="260" height="76" /></a>